返回 Agenda
Session 5: The Pricing and Reimbursement Perspective
Speaker(s)
Status quo of ATMP Launches in Europe
Alexander Natz, JD
European Confederation of Pharmaceutical Entrepreneurs, Belgium
Secretary General
ATMPs from the HTA Viewpoint – Learnings until now
Helen Knight
National Institute for Health and Care Excellence (NICE), United Kingdom
Programme Director
Payer Considerations
Michela Gabaldo, PharmD, MSc
Evotec, Italy
VP ATMP Global Regulatory Affairs
